CN Patent

CN101005857A — 多肽延长标记

Assigned to Novo Nordisk AS · Expires 2007-07-25 · 19y expired

What this patent protects

增加化合物在血浆中的半衰期的方法和这类化合物的新颖衍生物。

USPTO Abstract

增加化合物在血浆中的半衰期的方法和这类化合物的新颖衍生物。

Drugs covered by this patent

Patent Metadata

Patent number
CN101005857A
Jurisdiction
CN
Classification
—
Expires
2007-07-25
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.